$591.2
UnitedHealth Group Inc is a healthcare company that provides various health-related products and services, including insurance, pharmacy benefit management, and health information technology.
0.44%
Downside
Day's Volatility :1.17%
Upside
0.73%
26.19%
Downside
52 Weeks Volatility :28.22%
Upside
2.75%
Period | Unitedhealth Group Incorporated | Sector (Health Care) | Index (NASDAQ Composite) |
---|---|---|---|
3 Months | 20.82% | 5.0% | 7.6% |
6 Months | 29.65% | 5.9% | 8.9% |
1 Year | 12.29% | 16.6% | 26.8% |
3 Years | 46.08% | 18.9% | 21.9% |
Market Capitalization | 545.9B |
Book Value | $97.02 |
Dividend Share | 7.74 |
Dividend Yield | 1.42% |
Earnings Per Share (EPS) | 15.13 |
PE Ratio | 39.07 |
PEG Ratio | 1.49 |
Wall Street Target Price | 623.61 |
Profit Margin | 3.66% |
Operating Margin TTM | 7.97% |
Return On Assets TTM | 7.07% |
Return On Equity TTM | 15.58% |
Revenue TTM | 385.4B |
Revenue Per Share TTM | 417.59 |
Quarterly Revenue Growth YOY | 6.4% |
Gross Profit TTM | 79.6B |
EBITDA | 34.8B |
Diluted Eps TTM | 15.13 |
Quarterly Earnings Growth YOY | -0.22 |
EPS Estimate Current Year | 27.71 |
EPS Estimate Next Year | 31.17 |
EPS Estimate Current Quarter | 6.66 |
EPS Estimate Next Quarter | 7.19 |
What analysts predicted
Upside of 5.48%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 224.9B | ↑ 12.36% |
Net Income | 12.0B | ↑ 13.53% |
Net Profit Margin | 5.33% | ↑ 0.05% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 240.3B | ↑ 6.85% |
Net Income | 13.8B | ↑ 15.46% |
Net Profit Margin | 5.76% | ↑ 0.43% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 255.6B | ↑ 6.4% |
Net Income | 15.4B | ↑ 11.3% |
Net Profit Margin | 6.03% | ↑ 0.27% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 285.3B | ↑ 11.59% |
Net Income | 17.3B | ↑ 12.22% |
Net Profit Margin | 6.06% | ↑ 0.03% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 322.1B | ↑ 12.92% |
Net Income | 20.1B | ↑ 16.4% |
Net Profit Margin | 6.25% | ↑ 0.19% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 367.5B | ↑ 14.09% |
Net Income | 22.4B | ↑ 11.24% |
Net Profit Margin | 6.09% | ↓ 0.16% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 91.1B | ↑ 11.23% |
Net Income | 5.6B | ↑ 17.85% |
Net Profit Margin | 6.16% | ↑ 0.35% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 91.8B | ↑ 0.72% |
Net Income | 5.5B | ↓ 2.44% |
Net Profit Margin | 5.96% | ↓ 0.2% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 91.4B | ↓ 0.46% |
Net Income | 5.8B | ↑ 6.7% |
Net Profit Margin | 6.39% | ↑ 0.43% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 93.2B | ↑ 2.06% |
Net Income | 5.5B | ↓ 6.61% |
Net Profit Margin | 5.85% | ↓ 0.54% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 98.8B | ↑ 5.94% |
Net Income | -1.4B | ↓ 125.83% |
Net Profit Margin | -1.43% | ↓ 7.28% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 97.9B | ↓ 0.94% |
Net Income | 4.2B | ↓ 399.22% |
Net Profit Margin | 4.31% | ↑ 5.74% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 152.2B | ↑ 9.47% |
Total Liabilities | 96.0B | ↑ 10.29% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 173.9B | ↑ 14.23% |
Total Liabilities | 111.7B | ↑ 16.39% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 197.3B | ↑ 13.46% |
Total Liabilities | 126.8B | ↑ 13.45% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 212.2B | ↑ 7.56% |
Total Liabilities | 135.7B | ↑ 7.08% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 245.7B | ↑ 15.79% |
Total Liabilities | 159.4B | ↑ 17.41% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 278.4B | ↑ 13.31% |
Total Liabilities | 179.5B | ↑ 12.64% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 283.7B | ↑ 15.46% |
Total Liabilities | 193.1B | ↑ 21.15% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 280.2B | ↓ 1.24% |
Total Liabilities | 188.0B | ↓ 2.62% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 282.1B | ↑ 0.68% |
Total Liabilities | 188.1B | ↑ 0.04% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 278.4B | ↓ 1.29% |
Total Liabilities | 179.5B | ↓ 4.57% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 284.2B | ↑ 2.08% |
Total Liabilities | 187.3B | ↑ 4.34% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 286.1B | ↑ 0.65% |
Total Liabilities | 186.8B | ↓ 0.25% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 15.7B | ↑ 15.57% |
Investing Cash Flow | -12.4B | ↑ 44.03% |
Financing Cash Flow | -4.4B | ↑ 26.85% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 18.5B | ↑ 17.5% |
Investing Cash Flow | -12.7B | ↑ 2.54% |
Financing Cash Flow | -5.6B | ↑ 28.87% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 22.2B | ↑ 20.1% |
Investing Cash Flow | -12.5B | ↓ 1.32% |
Financing Cash Flow | -3.6B | ↓ 36.18% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 22.3B | ↑ 0.76% |
Investing Cash Flow | -10.4B | ↓ 17.24% |
Financing Cash Flow | -7.5B | ↑ 107.66% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 26.2B | ↑ 17.29% |
Investing Cash Flow | -28.5B | ↑ 174.55% |
Financing Cash Flow | 4.2B | ↓ 156.69% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 16.3B | ↓ 460.18% |
Investing Cash Flow | -11.0B | ↓ 61.3% |
Financing Cash Flow | 13.2B | ↑ 200.32% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 11.0B | ↓ 32.43% |
Investing Cash Flow | -11.7B | ↑ 6.61% |
Financing Cash Flow | -10.5B | ↓ 179.29% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 6.9B | ↓ 37.44% |
Investing Cash Flow | -14.4B | ↑ 22.46% |
Financing Cash Flow | -7.1B | ↓ 32.08% |
Sell
Neutral
Buy
Unitedhealth Group Incorporated is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Unitedhealth Group Incorporated | -0.49% | 29.65% | 12.29% | 46.08% | 167.22% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Unitedhealth Group Incorporated | 39.07 | 39.07 | 1.49 | 27.71 | 0.16 | 0.07 | 0.01 | 97.02 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Unitedhealth Group Incorporated | Buy | $545.9B | 167.22% | 39.07 | 3.66% |
Insights on Unitedhealth Group Incorporated
Revenue is down for the last 2 quarters, 98.78B → 97.85B (in $), with an average decrease of 0.9% per quarter
Netprofit is up for the last 2 quarters, -1.40B → 4.21B (in $), with an average increase of 133.4% per quarter
Vanguard Group Inc
BlackRock Inc
State Street Corp
FMR Inc
Capital World Investors
T. Rowe Price Associates, Inc.
In the quarter ending March,2024. Unitedhealth Group Incorporated has declared dividend of $1.88
Read MoreUnitedHealth Group Inc. is a rapidly expanding health care and well-being company with customers in different parts of the world. These institutions affiliated with the UnitedHealth Group Inc. may provide better health facilities and exceptional medical benefits to their customers. Customers want safe, secure, and hygienic medical facilities and dispensaries for surgeries, heart transplants, cancer operations, chemotherapy, and other procedures. UnitedHealth Group Inc. has adopted a loan and financial savings model to cater to the demands of their customers who are facing shortage of essential medical funds, operation/surgery costs, transportation costs for cure, and many other issues. Since its inception in the year 1977, UnitedHealth Group Inc. has established itself as a reputable and well-known organisation in the eyes of international communities from across the globe. UnitedHealth Group Inc. was one of the first companies to use technological advancements in the healthcare industry to attract rich and powerful customers from different parts of the world in the multibillion-dollar well-being industry market. UnitedHealth Inc. is dedicated to increasing the reach and accessibility of its market services to underdeveloped and developing nations. Over the next decade, Healthcare and personal well-being sectors of the global economy have the potential to outpace current levels of consumption and customer demands for better well-being alternatives. Currently Unitedhealth Group Incorporated has a market cap of $546.27 Billion. It has a P.E ratio of 38.73. The shares of Unitedhealth Group Incorporated are trading at $591.2. .
Organization | Unitedhealth Group Incorporated |
Employees | 440000 |
CEO | Sir Andrew Philip Witty |
Industry | Health Services |